Clinical trials: Chronic Hepatic Pruritus

Pruritus

Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus

• Completed
• Age: 18 years and older
• Phase 2
• Injection or infusion
• Results posted

To investigate the potential efficacy of dupilumab in the treatment of moderate to severe chronic hepatic pruritus.

Trial name

NCT04256759

Testing

Dupilumab 300Mg Solution for Injection

Where

United States

Volunteers

9 people

Sponsor

Mayo Clinic